Invus Financial Advisors’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $7.12M | Hold |
1,007,575
| – | – | 7.98% | 4 |
|
|
2024
Q1 | $13.9M | Hold |
1,007,575
| – | – | 11.01% | 4 |
|
|
2023
Q4 | $9.27M | Hold |
1,007,575
| – | – | 7.25% | 5 |
|
|
2023
Q3 | $6.1M | Hold |
1,007,575
| – | – | 3.82% | 6 |
|
|
2023
Q2 | $7.82M | Hold |
1,007,575
| – | – | 4.18% | 8 |
|
|
2023
Q1 | $5.74M | Hold |
1,007,575
| – | – | 3.74% | 7 |
|
|
2022
Q4 | $5.93M | Hold |
1,007,575
| – | – | 3.16% | 7 |
|
|
2022
Q3 | $3.22M | Hold |
1,007,575
| – | – | 1.77% | 8 |
|
|
2022
Q2 | $4.51M | Hold |
1,007,575
| – | – | 2.73% | 7 |
|
|
2022
Q1 | $5.38M | Hold |
1,007,575
| – | – | 2.39% | 7 |
|
|
2021
Q4 | $14.8M | Hold |
1,007,575
| – | – | 4.5% | 7 |
|
|
2021
Q3 | $21.1M | Hold |
1,007,575
| – | – | 5.64% | 7 |
|
|
2021
Q2 | $17.8M | Hold |
1,007,575
| – | – | 3.55% | 7 |
|
|
2021
Q1 | $24.7M | Hold |
1,007,575
| – | – | 5.66% | 6 |
|
|
2020
Q4 | $34.1M | Sell |
1,007,575
-1
| -0% | -$34 | 14.26% | 5 |
|
|
2020
Q3 | $25.2M | Hold |
1,007,576
| – | – | 12.12% | 5 |
|
|
2020
Q2 | $34M | Buy |
+1,007,576
| New | +$34M | 12.28% | 4 |
|